M26.01
Maxillary hyperplasia
Clinical Classification Guidelines
Medical Intelligence & Overview
Maxillary hyperplasia is a medical condition characterized by an abnormal, excessive growth of the maxilla, which is the upper jawbone. This condition can lead to facial deformities, dental issues, and functional problems such as difficulty in speaking or chewing. Recognizing the symptoms and understanding the causes can help in managing the condition effectively with appropriate medical intervention.
Causes & Symptoms
Clinical Causes: Genetic factors that influence bone growth patterns Developmental anomalies present at birth Certain syndromes that involve abnormal craniofacial development Environmental influences such as prolonged mouth breathing or thumb sucking during childhood In rare cases, infections or inflammatory conditions affecting the maxilla
Key Symptoms: Prominent or protruding upper jaw Teeth misalignment or crowding in the upper dental arch Facial asymmetry or uneven jaw growth Difficulty closing the mouth properly Speech difficulties due to altered oral cavity structure Difficulty chewing or biting Potential breathing issues if associated with airway obstruction
Diagnostic & Treatment
Diagnosis Path: Diagnosis of maxillary hyperplasia usually involves a comprehensive clinical examination by a dental or medical specialist. Imaging studies such as X-rays, CT scans, or panoramic radiographs are essential to assess the extent of bone overgrowth and to plan appropriate treatment. Additionally, a detailed medical history and examination of facial growth patterns contribute to an accurate diagnosis.
Treatment Protocols: Treatment approaches are tailored according to the severity and underlying causes of the hyperplasia. They may include:
Clinical Advice & FAQs
Billing Guidance
Is M26.01 a billable ICD-10 code?
Yes, M26.01 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M26.01?
Clinical documentation must specify the nature of Maxillary hyperplasia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
